XRF Scientific Limited (XRF.AX)
AUD 1.75
(2.65%)
AUD 1.75
(2.65%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 15.32 Million AUD | 15.95% |
| 2023 | 13.21 Million AUD | 40.14% |
| 2022 | 9.43 Million AUD | 30.92% |
| 2021 | 8.05 Million AUD | 25.12% |
| 2020 | 5.85 Million AUD | 51.75% |
| 2019 | 4.21 Million AUD | 64.98% |
| 2018 | 2.45 Million AUD | 30.78% |
| 2017 | 1.85 Million AUD | -36.85% |
| 2016 | 3.07 Million AUD | -29.12% |
| 2015 | 4.21 Million AUD | -2.5% |
| 2014 | 4.18 Million AUD | -26.01% |
| 2013 | 5.75 Million AUD | -1.47% |
| 2012 | 5.84 Million AUD | 23.05% |
| 2011 | 4.41 Million AUD | 312.55% |
| 2010 | 852 Thousand AUD | -55.6% |
| 2009 | 2.59 Million AUD | 39.33% |
| 2008 | 1.83 Million AUD | 100.83% |
| 2007 | 743.54 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | 14.77% |
| 2024 Q4 | 8.55 Million AUD | 0.0% |
| 2024 Q2 | 7.46 Million AUD | 0.0% |
| 2023 FY | - AUD | 40.14% |
| 2023 Q2 | 6.69 Million AUD | 0.0% |
| 2023 Q4 | 7.26 Million AUD | 0.0% |
| 2022 Q4 | 5.5 Million AUD | 0.0% |
| 2022 FY | - AUD | 30.92% |
| 2022 Q2 | 4.45 Million AUD | 0.0% |
| 2021 Q2 | 3.23 Million AUD | 0.0% |
| 2021 FY | - AUD | 25.12% |
| 2021 Q4 | 4.37 Million AUD | 0.0% |
| 2020 FY | - AUD | 51.75% |
| 2020 Q2 | 3.29 Million AUD | 0.0% |
| 2020 Q4 | 2.79 Million AUD | 0.0% |
| 2019 FY | - AUD | 64.98% |
| 2019 Q2 | 2.23 Million AUD | 0.0% |
| 2019 Q4 | 2.26 Million AUD | 0.0% |
| 2018 Q4 | 1.24 Million AUD | 0.0% |
| 2018 FY | - AUD | 30.78% |
| 2018 Q2 | 1.18 Million AUD | 0.0% |
| 2017 Q4 | 925.93 Thousand AUD | 0.0% |
| 2017 Q2 | 932.04 Thousand AUD | 0.0% |
| 2017 FY | - AUD | -36.85% |
| 2016 Q4 | 1.3 Million AUD | 0.0% |
| 2016 FY | - AUD | -29.12% |
| 2016 Q2 | 1.64 Million AUD | 0.0% |
| 2015 Q4 | 1.71 Million AUD | 0.0% |
| 2015 Q2 | 2.43 Million AUD | 0.0% |
| 2015 FY | - AUD | -2.5% |
| 2014 FY | - AUD | -26.01% |
| 2014 Q2 | 2.19 Million AUD | 0.0% |
| 2014 Q4 | 2.05 Million AUD | 0.0% |
| 2013 Q3 | 1.43 Million AUD | 0.0% |
| 2013 Q1 | 1.45 Million AUD | 0.0% |
| 2013 FY | - AUD | -1.47% |
| 2013 Q4 | 2.11 Million AUD | 46.85% |
| 2013 Q2 | 1.43 Million AUD | -1.03% |
| 2012 Q3 | 1.45 Million AUD | 0.0% |
| 2012 Q4 | 1.45 Million AUD | 0.0% |
| 2012 Q2 | 1.45 Million AUD | 31.66% |
| 2012 Q1 | 1.1 Million AUD | 0.0% |
| 2012 FY | - AUD | 23.05% |
| 2011 Q4 | 1.1 Million AUD | 0.0% |
| 2011 Q3 | 1.1 Million AUD | 0.0% |
| 2011 Q2 | 1.1 Million AUD | 418.33% |
| 2011 FY | - AUD | 312.55% |
| 2011 Q1 | 212.99 Thousand AUD | 0.0% |
| 2010 Q2 | 212.99 Thousand AUD | -67.12% |
| 2010 Q3 | 212.99 Thousand AUD | 0.0% |
| 2010 Q1 | 647.81 Thousand AUD | 0.0% |
| 2010 FY | - AUD | -55.6% |
| 2010 Q4 | 212.99 Thousand AUD | 0.0% |
| 2009 FY | - AUD | 39.33% |
| 2009 Q4 | 647.81 Thousand AUD | 0.0% |
| 2009 Q3 | 647.81 Thousand AUD | 0.0% |
| 2009 Q2 | 647.81 Thousand AUD | 41.09% |
| 2009 Q1 | 459.13 Thousand AUD | 0.0% |
| 2008 Q4 | 459.13 Thousand AUD | 0.0% |
| 2008 Q2 | 459.13 Thousand AUD | 213.66% |
| 2008 Q1 | 146.37 Thousand AUD | 0.0% |
| 2008 Q3 | 459.13 Thousand AUD | 0.0% |
| 2008 FY | - AUD | 100.83% |
| 2007 Q4 | 146.37 Thousand AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q3 | 146.37 Thousand AUD | 0.0% |
| 2007 Q2 | 146.37 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Audinate Group Limited | 24.41 Million AUD | 37.237% |
| Codan Limited | 147.52 Million AUD | 89.613% |
| Hydrix Limited | -4.12 Million AUD | 471.895% |
| Optiscan Imaging Limited | -6.46 Million AUD | 337.055% |
| Shekel Brainweigh Ltd. | -3.51 Million AUD | 535.601% |
| Structural Monitoring Systems Plc | 1.99 Million AUD | -668.871% |
| X2M Connect Limited | -4.44 Million AUD | 444.687% |
| Zimi Limited | -1.64 Million AUD | 1031.943% |